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Zinc Deficiency Leads to Lipid Changes in Drosophila Brain
Similar to Cognitive-Impairing Drugs: An Imaging Mass
Spectrometry Study
Mai H. Philipsen+,[b] Chaoyi Gu+,[a] and Andrew G. Ewing*[a]
Several diseases and disorders have been suggested to be
associated with zinc deficiency, especially learning and memory
impairment. To have better understanding about the connec-
tion between lipid changes and cognitive impairments, we
investigated the effects of a zinc-chelated diet on certain brain
lipids of Drosophila melanogaster by using time-of-flight secon-
dary ion mass spectrometry (ToF-SIMS). The data revealed that
there are increases in the levels of phosphatidylcholine and
phosphatidylinositol in the central brains of the zinc-deficient
flies compared to the control flies. In contrast, the abundance
of phosphatidylethanolamine in the brains of the zinc-deficient
flies is lower. These data are consistent with that of cognitive-
diminishing drugs, thus providing insight into the biological
and molecular effects of zinc deficiency on the major brain
lipids and opening a new treatment target for cognitive deficit
in zinc deficiency.
Zinc is an essential trace element that plays important roles in
various functions of the central nervous system, such as
modulation of neurotransmitter activity, enzymatic activity, and
cellular signaling.[1] Zinc is highly abundant in the brain and a
high fraction of zinc ions either bind to proteins or are required
for enzymatic functions. As zinc has been shown to bind
approximately 10% of human proteins, a lack of this trace
element leads to severe problems in brain functions during
growth and development.[2] Zinc deficiency has been suggested
to induce oxidative stress as well as disrupt growth factor
signaling molecules, and thus induce neuronal apoptosis.[3] In
addition to that, zinc deficiency during pregnancy leads to
elevated risk of abortion, low birth weight and negative effects
on the birth process.[4] Zinc accumulates significantly in the
hippocampus in brain and is essential for hippocampus-
dependent memory.[5] Although chronic zinc deficiency affects
signaling molecules that are involved in memory formation,
other possible pathways through which zinc deficiency impairs
learning and memory remain to be understood.[6] Lipids, the
major component of cellular membranes, are shown to be
altered by cognition-related drugs.[7] Additionally, the effects of
zinc deficiency on lipid compositions have been demonstrated
in rats and cells.[8] Therefore, we have examined the possible
correlation between lipid alterations and zinc deficiency-
induced memory impairment.
Many analytical methods are available for analysis of
lipidomics, including mass spectrometric imaging (MSI), liquid
chromatography  mass spectrometry, and other mass spectrom-
etry-based techniques.[7a,9] Among them, MSI is a powerful tool
to probe and provide spatial information of lipid species within
biological samples. ToF-SIMS, a label-free MSI technique, has
been used in a range of biomedical studies on cells and tissues
due to its low detection limit and high spatial resolution.
Recently, ToF-SIMS has been applied as an approach to analyze
lipidomics in diseases and disorders, including cancer, fatty
liver, cardiovascular disease, Alzheimer’s disease, and so on.[10]
In addition to that, certain medications or diets have also been
shown to be able to induce changes in lipid structures and
composition in the brain.[9d,11] In this study, we investigated the
alterations of lipids in the fly brain caused by dietary zinc
chelation using ToF-SIMS. ToF-SIMS imaging was performed
using the ToF SIMS V (ION-TOF GmbH) with a 25 keV Bi3
+ +
primary ion source. The use of a cluster primary ion beam
provides the possibility to obtain images of tissue sections at
micron spatial resolution and spectra with a wide mass range,
while the sample preparation remains relatively simple.
Drosophila melanogaster, the fruit fly, is an attractive model
for studying zinc deficiency as the machinery for transporting
and regulating zinc in Drosophila is similar to that in
mammals.[12] Moreover, the metal-responsive transcription fac-
tor-1 and its transcriptional targets, which are important in
maintaining cellular zinc homeostasis in mammals to avoid
heavy-metal-induced toxicity, are discovered in flies.[13]
Zinc deficiency in flies can be induced by two methods,
genetic manipulation or modification of standard fly food with
chelating agents that show high affinity for zinc, such as
N,N,N’,N’-tetrakis(2-pyridinylmethyl)ethanediamine (TPEN).[14]
Although TPEN also has effects on other metal ions, including
iron and copper, the iron level in flies are not significantly
affected by food supplemented with TPEN.[14c,15] In our experi-
ments, 100 μM TPEN was used to chelate a portion of zinc from
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the standard fly food to generate zinc-chelated food, whereas
control flies were given the standard food throughout the
entire life cycle. Even though it was clearly observed that the
growth of the flies fed with zinc-chelated food was retarded,
how much zinc remained inside the fly was unclear. To answer
this question, inductively coupled plasma mass spectrometry
(ICP-MS) was performed to quantify the concentration of zinc in
control as well as zinc-deficient larvae and flies (Figure S1 in the
Supporting Information). We found that the average concen-
tration of zinc in control and zinc-deficient larvae were 941.01
and 312.29 ppb, respectively, meaning that the zinc-chelated
food effectively reduced < B2=3 > of the total zinc level inside
the fly larvae. Moreover, zinc-chelated food also cut the total
zinc level in the body of the adult fly to half. This decreased
level of zinc might be due to that the chelated zinc is more
readily excreted by the flies. It is noticeable that the concen-
tration of zinc inside the head of the adult fly is much lower
than the concentration in the fly body. However, by feeding the
flies with zinc-chelated food, the zinc concentration in the fly
head decreased but not significantly (decreased from 284.57 to
214.96 ppb). In Drosophila, dietary zinc is stored in Malpighian
tubules and the expression of Zip71B, the protein responsible
for zinc detoxification and importing zinc across the membrane,
can be regulated with dietary zinc to maintain zinc homeostasis
inside the fly body.[16] The total zinc level in the brain, on the
other hand, has been suggested to be more tightly controlled
and barely affected by peripheral zinc level.[17] This might
explain why zinc-chelated diet influences zinc concentration in
the fly body more significantly than in the fly brain.
Prior to ToF-SIMS analysis, flies were placed on fly collars
and frozen in order to separate the heads from the bodies. The
heads were subsequently sectioned into thin slices with a
thickness of 12 μm under   20 °C and thaw-mounted on glasses
coated with indium tin oxide (ITO). The sliced samples were
then freeze-dried under vacuum right before the analysis and
ToF-SIMS equipped with a 25 keV Bi3
+ + primary ion beam was
used for the entire analysis. Figure 1 shows the ion images of
phosphatidylcholine (PC) fragments at m/z 184.1 and 224.1 as
well as phosphatidylethanolamine (PE) fragment at m/z 140.0
obtained from ToF-SIMS analysis. PC and PE fragments are
caused by the bombardment of primary ion beam on the
surface of the sample. Zinc deficiency leads to increases of the
intensities of the PC fragments at m/z 184.1 and 224.1 in the
entire fly head, particularly in the area of the central brain,
whereas the zinc chelated diet induces a decrease of the
intensity of PE fragment at m/z 140.0, and this decrease is more
obvious in the central brain region and the optical lobula.
To obtain specific information regarding how dietary zinc
chelation affects the brain, we imaged the area of the central
brains of fly heads to perform data analysis. As the spectra from
ToF-SIMS experiments contain much higher intensities of lipid
fragments than lipid molecules, specifically in the mass region
with m/z less than 300, principal component analysis (PCA) was
performed only in the mass range between 650 and 900 to
examine molecular ions. PCA is a multivariate data analysis
method and can be applied to analyze variations within the
lipid region between samples of control and zinc-deficient flies.
The image output score in positive ion mode is plotted in
Figure 2A and reveals the separation between control and zinc-
deficient groups along principal component 3. The correspond-
ing loading plot, which is shown in Figure 2B, demonstrates the
peaks contributing to the separation of these two groups.
Elevated intensities of various PC species and their salt adducts,
Figure 1. Distribution of PC fragments at m/z 184.1 and 224.1 in positive-ion
mode and PE fragment at m/z 140.0 in negative-ion mode in the brains of
control and zinc-deficiency flies. All data were acquired by using ToF-SIMS
equipped with a 25 keV Bi3
+ +, and the total ion dose was 1.5 x 1012 ions/
cm2. The symbolic image on the top left illustrates the structure of the fly
head, including medulla of optic lobes (the two red parts), optical lobula
(the two green parts), the central brain (the yellow region in the middle) and
proboscis (the gray area).
Figure 2. PCA of positive-ion-mode data of the central brain regions of
control versus zinc-deficient flies from the ToF-SIMS experiment. A) Score
plot of principal component 1 versus principal component 3 from the
spectra. B) Corresponding loading plot of principal component 3 showing
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including PC (32 :1) at m/z 732.6, PC (34 :2) at m/z 758.6, PC
(34 :1) at m/z 760.6, PC (36 :4) at m/z 782.6, PC (34 :1)+K at m/z
798.5 and PC (36 :2)+Na at m/z 808.6, are observed after zinc
chelated diet. These observations are consistent with the
increased intensity of PC fragments at m/z 184.1 in the samples
of fly head upon zinc deficiency. In contrast, the levels of
triacylglycerols (TAGs) are more dominant in control samples,
such as TAG (48:0) at m/z 807.6 and TAG (46 :1)+K at m/z
815.7.
In negative-ion mode, the control and the zinc-deficient
groups are again clearly separated along principal component
3, as can be seen in Figure 3A. The associated loading plot of
principal component 3, as plotted in Figure 3B, shows the PE
and phosphatidylinositol (PI) species that are responsible for
the separation in this principal component. PI species, such as
PI (32 :1) at m/z 807.5 and PI (34 :1) at m/z 835.5, are less
abundant in control flies. Similar to PI species, the reductions of
PE (34 :1) at m/z 716.5 and PE (34 :2) at m/z 714.5 are observed
in the central brain of the control group as well. In contrast, the
control flies have higher level of PE (36 :1) at m/z 744.5 as well
as PE (36 :2) at m/z 742.5 compared to the zinc-deficient flies.
Based on the results obtained from PCA, the relative
intensities of the lipid species in central fly brain which
contribute to the separation in the PCA were examined and
these are illustrated in Figure 4. Unsaturated PC species, which
are detected as [M+H]+, and their salt adducts have increased
intensities upon dietary zinc chelation. In negative-ion mode,
the increases of the abundance of a variety of PI species in the
central brain region, such as PI (32 :1) at m/z 807.5, PI (32 :0) at
m/z 809.6, PI (34 :2) at m/z 833.5, PI (34 :1) at m/z 835.5 and PI
(34 :0) at m/z 837.6, are induced by the diet with zinc chelation.
Moreover, the signal of the PI fragment at m/z 241.0, which is
related to the lipid species of PI, is also elevated in the central
brains of the flies fed with the zinc chelated diet. For PE lipid
species, the data in Figure 4 show that the abundance of PE
with 34 carbons in the fatty acid tails increases, whereas the
zinc chelated diet lowers the intensities of PE with 36 carbons
in the fatty acid tails.
Dietary zinc chelation induces the elevations of PC and PI
levels and the depletion of total PE level in the central fly brain.
Consistent with our data, Carman et al. reported an increased
level of PI and decreased level of PE in cells upon depletion of
zinc.[8b] The activities of most enzymes in the CDP-diacylglycerol
pathway, including phosphatidylserine synthase and decarbox-
ylase, appear to be decreased in response to zinc deficiency
and thus, this condition results in a decreased PE level.[18] In
contrast, by upregulating the activity of PI synthase, zinc
deficiency elevates the level of PI. Moreover, the abundance of
PC is significantly increased upon zinc deficiency because of the
enhanced activity of the choline phosphotransferase.[19]
Previous studies on neuroendocrine cells reveal that zinc
treatment increases the levels of PC lipid species while it
decreases the abundance of PEs in the cellular membrane,
which resembles the changes of lipid species caused by zinc
deficiency shown here for Drosophila brain.[20] The changes
observed for PIs, however, appear to be opposite to these
between zinc treatment and zinc deficiency. The TPEN post-
treatment brought the levels of the lipids slightly but not
completely back to the control level, demonstrating apparently
irreversible effects to the cellular membrane induced by zinc
treatment. It is well accepted that zinc deficiency can cause the
impairment of learning and memory, but the mechanisms
regarding how zinc administration influences cognitive process
are not fully understood yet. It seems that zinc administration
might have biphasic effects, with high concentration being
neurotoxic and low concentration being neuroprotective,
especially for post injury conditions.[21]
In agreement with our data, cognitive impairing drugs, such
as ketamine and cocaine, induce similar changes in lipid
composition compared to zinc deficiency. Acute and chronic
usage of ketamine, a medication that is used as an anesthetic
as well as a treatment for depressive disorder, has been shown
to exhibit negative effects on cognition and by treating the
depressive disorder patients with ketamine, increased concen-
trations of phospholipid, particularly PC, were observed.[22] The
effects of zinc deficiency on the abundance of certain lipid
Figure 3. PCA of negative-ion-mode data of the central brain regions of
control versus zinc-deficient flies from the ToF-SIMS experiment. A) Score
plot of principal component 2 versus principal component 3 from the
spectra. B) Corresponding loading plot of principal component 3 showing
the peaks that contribute to the separation of the two fly groups.
Figure 4. Relative quantification of A) PC species and B) PE and PI species in
the central brains of control and zinc-deficient flies. Images were obtained in
positive- and negative-ion modes by using 25 keV Bi3
+ + as the primary ion
source. Data were collected from 24 fly heads for both groups with each
measurement repeated 3 times. Peak intensities were normalized to
numbers of selected pixels and total peak intensity. The error bars represent
SEM and show variations among different fly heads. PC species were
detected as [M+H]+ unless specified as Na/K adduct species. PE and PI
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species are similar to the effects induced by the administration
of cocaine, a drug that leads to a decline in cognition.[7a] To be
more specific, these similar effects include that both zinc
deficiency and cocaine administration elevate the levels of PC
species as well as PE (34 :1), PE (34 :2), PI (34 :1) and PI (34 :2),
while they both reduce the signals of several other PE species,
including PE (36 :3) and PE (36 :2). In contrast, methylphenidate,
a psychostimulant that has similar action as cocaine on the
dopamine transporter but appears to enhance cognitive
performance and memory, changes the intensities of lipid
species opposite to cocaine.[7a]
In mammals, zinc is stored in synaptic vesicles and is
released together with glutamate during exocytosis of gluta-
matergic neurons. This released zinc can subsequently modu-
late certain receptors and ion channels, suggesting the
importance of zinc in regulating learning and memory.[1b,23] Zinc
deficiency caused by diet is linked to cognitive impairment and
different pathways underlying this have been proposed.[24]
Based on our study, it seems quite possible that in the brain,
alterations of the abundance of certain lipid species are related
to improvement or impairment in cognition. Our study, when
compared to other studies focusing on cognition-related drugs,
suggests that the cognitive loss in the brain induced by zinc
deficiency could lead to an increased amount of PC, 34-carbon
chain PE, and 34-carbon chain PI, as well as a decreased amount
of 36-carbon chain PE.
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